Literature DB >> 26141076

A non-invasive prevention program model for the assessment of osteoporosis in the early postmenopausal period: a pilot study on FRAX(®) and QUS tools advantages.

P Villa1, A P Lassandro2, M C Moruzzi3, I D Amar3, L Vacca3, F Di Nardo4, C De Waure4, A Pontecorvi2, G Scambia3.   

Abstract

OBJECTIVE: The study analyses the performances of FRAX algorithm and quantitative ultrasound (QUS) tool in relationship to the dual-energy X-ray absorptiometry (DXA) categorization to identify patients at risk of osteoporosis during menopause and to reach new thresholds for recommending the first DXA examination.
DESIGN: Retrospective cohort study. PATIENTS AND MEASUREMENTS: Two hundred eighty-two postmenopausal patients filled out a questionnaire which determined their FRAX index and performed a bone evaluation by QUS of the calcaneus to determine their stiffness index (SI). Thereafter, they underwent assessments by the gold-standard DXA bone examination.
RESULTS: Statistically significant correlations were observed between FRAX (calculated without BMD) and both QUS and DXA diagnosis. FRAX mean indices of risk corresponding to the diagnosis of osteoporosis by QUS and DXA were similar. Receiver operating characteristic (ROC) curve analysis showed that both FRAX and QUS tests were sufficiently accurate in predicting the alteration of bone mineral composition. The ROC curves of QUS allowed us to identify, in our population, SI cutoff for normal patients (SI > 90.5) and for patients having osteoporosis (SI < 78.5). We selected a cutoff screening value from FRAX ROC curve for major clinical fracture (2.94). The following diagnostic algorithm demonstrated that the use of FRAX test alone has a sensitivity of 85.3 % and a specificity of 33.8 % while the use of QUS exam alone showed a sensitivity of 81.3 % and a specificity of 45.1 %. When considering the capacity of QUS exam in combination with FRAX test, the final algorithm showed a sensitivity of 69.4 % and a specificity of 57.7 %.
CONCLUSIONS: The use of QUS test with adjusted cutoffs offers a similar performance to the FRAX test alone in terms of sensitivity. The combined use of the tests reduces the sensibility but increases the specificity and adds clinical information related to the bone status of the patient.

Entities:  

Keywords:  FRAX; Menopause; Osteoporosis; QUS; Stiffness index

Mesh:

Year:  2015        PMID: 26141076     DOI: 10.1007/s40618-015-0341-4

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  33 in total

Review 1.  FRAX and its applications to clinical practice.

Authors:  John A Kanis; Anders Oden; Helena Johansson; Fredrik Borgström; Oskar Ström; Eugene McCloskey
Journal:  Bone       Date:  2009-02-03       Impact factor: 4.398

2.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis.

Authors:  Nelson B Watts; John P Bilezikian; Pauline M Camacho; Susan L Greenspan; Steven T Harris; Stephen F Hodgson; Michael Kleerekoper; Marjorie M Luckey; Michael R McClung; Rachel Pessah Pollack; Steven M Petak
Journal:  Endocr Pract       Date:  2010 Nov-Dec       Impact factor: 3.443

3.  QFracture is better than FRAX tool in assessing risk of hip fracture.

Authors:  Antony Johansen
Journal:  BMJ       Date:  2012-07-23

Review 4.  How many women have osteoporosis now?

Authors:  L J Melton
Journal:  J Bone Miner Res       Date:  1995-02       Impact factor: 6.741

Review 5.  The role of quantitative ultrasound in the assessment of bone: a review.

Authors:  S H Prins; H L Jørgensen; L V Jørgensen; C Hassager
Journal:  Clin Physiol       Date:  1998-01

6.  Updated fracture incidence rates for the Italian version of FRAX®.

Authors:  P Piscitelli; G Chitano; H Johannson; M L Brandi; J A Kanis; D M Black
Journal:  Osteoporos Int       Date:  2012-05-26       Impact factor: 4.507

7.  Were you identified to be at high fracture risk by FRAX® before your osteoporotic fracture occurred?

Authors:  Xiao-feng Chen; Xiao-lin Li; Hui Zhang; Ge-jun Liu
Journal:  Clin Rheumatol       Date:  2014-02-28       Impact factor: 2.980

8.  Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS Study.

Authors:  Claus C Glüer; Richard Eastell; David M Reid; Dieter Felsenberg; Christian Roux; Reinhard Barkmann; Wolfram Timm; Tilo Blenk; Gabi Armbrecht; Alison Stewart; Jackie Clowes; Friederike E Thomasius; Sami Kolta
Journal:  J Bone Miner Res       Date:  2004-03-01       Impact factor: 6.741

9.  Bone mineral density thresholds for pharmacological intervention to prevent fractures.

Authors:  Ethel S Siris; Ya-Ting Chen; Thomas A Abbott; Elizabeth Barrett-Connor; Paul D Miller; Lois E Wehren; Marc L Berger
Journal:  Arch Intern Med       Date:  2004-05-24

10.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Authors:  J A Kanis; E V McCloskey; H Johansson; C Cooper; R Rizzoli; J-Y Reginster
Journal:  Osteoporos Int       Date:  2012-10-19       Impact factor: 4.507

View more
  1 in total

Review 1.  Advances in imaging approaches to fracture risk evaluation.

Authors:  Mary Kate Manhard; Jeffry S Nyman; Mark D Does
Journal:  Transl Res       Date:  2016-10-17       Impact factor: 7.012

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.